These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 16963482)

  • 1. Clinical and molecular cytogenetic characterisation of a newly recognised microdeletion syndrome involving 2p15-16.1.
    Rajcan-Separovic E; Harvard C; Liu X; McGillivray B; Hall JG; Qiao Y; Hurlburt J; Hildebrand J; Mickelson EC; Holden JJ; Lewis ME
    J Med Genet; 2007 Apr; 44(4):269-76. PubMed ID: 16963482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A variant Cri du Chat phenotype and autism spectrum disorder in a subject with de novo cryptic microdeletions involving 5p15.2 and 3p24.3-25 detected using whole genomic array CGH.
    Harvard C; Malenfant P; Koochek M; Creighton S; Mickelson EC; Holden JJ; Lewis ME; Rajcan-Separovic E
    Clin Genet; 2005 Apr; 67(4):341-51. PubMed ID: 15733271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A newly recognised microdeletion syndrome of 2p15-16.1 manifesting moderate developmental delay, autistic behaviour, short stature, microcephaly, and dysmorphic features: a new patient with 3.2 Mb deletion.
    Liang JS; Shimojima K; Ohno K; Sugiura C; Une Y; Ohno K; Yamamoto T
    J Med Genet; 2009 Sep; 46(9):645-7. PubMed ID: 19724011
    [No Abstract]   [Full Text] [Related]  

  • 4. Microdeletion at chromosome 4q21 defines a new emerging syndrome with marked growth restriction, mental retardation and absent or severely delayed speech.
    Bonnet C; Andrieux J; Béri-Dexheimer M; Leheup B; Boute O; Manouvrier S; Delobel B; Copin H; Receveur A; Mathieu M; Thiriez G; Le Caignec C; David A; de Blois MC; Malan V; Philippe A; Cormier-Daire V; Colleaux L; Flori E; Dollfus H; Pelletier V; Thauvin-Robinet C; Masurel-Paulet A; Faivre L; Tardieu M; Bahi-Buisson N; Callier P; Mugneret F; Edery P; Jonveaux P; Sanlaville D
    J Med Genet; 2010 Jun; 47(6):377-84. PubMed ID: 20522426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain malformations in a patient with deletion 2p16.1: A refinement of the phenotype to BCL11A.
    Balci TB; Sawyer SL; Davila J; Humphreys P; Dyment DA
    Eur J Med Genet; 2015; 58(6-7):351-4. PubMed ID: 25979662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation.
    Battaglia A; Hoyme HE; Dallapiccola B; Zackai E; Hudgins L; McDonald-McGinn D; Bahi-Buisson N; Romano C; Williams CA; Brailey LL; Zuberi SM; Carey JC
    Pediatrics; 2008 Feb; 121(2):404-10. PubMed ID: 18245432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromosome 2p15p16.1 microdeletion syndrome: 2.5 Mb deletion in a patient with renal anomalies, intractable seizures and a choledochal cyst.
    Hucthagowder V; Liu TC; Paciorkowski AR; Thio LL; Keller MS; Anderson CD; Herman T; Dehner LP; Grange DK; Kulkarni S
    Eur J Med Genet; 2012; 55(8-9):485-9. PubMed ID: 22579565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a patient with intellectual disability and de novo 3.7 Mb deletion supports the existence of a novel microdeletion syndrome in 2p14-p15.
    Hancarova M; Vejvalkova S; Trkova M; Drabova J; Dleskova A; Vlckova M; Sedlacek Z
    Gene; 2013 Mar; 516(1):158-61. PubMed ID: 23266801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes.
    Bruno DL; Anderlid BM; Lindstrand A; van Ravenswaaij-Arts C; Ganesamoorthy D; Lundin J; Martin CL; Douglas J; Nowak C; Adam MP; Kooy RF; Van der Aa N; Reyniers E; Vandeweyer G; Stolte-Dijkstra I; Dijkhuizen T; Yeung A; Delatycki M; Borgström B; Thelin L; Cardoso C; van Bon B; Pfundt R; de Vries BB; Wallin A; Amor DJ; James PA; Slater HR; Schoumans J
    J Med Genet; 2010 May; 47(5):299-311. PubMed ID: 20452996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New cases and refinement of the critical region in the 1q41q42 microdeletion syndrome.
    Rosenfeld JA; Lacassie Y; El-Khechen D; Escobar LF; Reggin J; Heuer C; Chen E; Jenkins LS; Collins AT; Zinner S; Babcock M; Morrow B; Schultz RA; Torchia BS; Ballif BC; Tsuchiya KD; Shaffer LG
    Eur J Med Genet; 2011; 54(1):42-9. PubMed ID: 20951845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 19q13.11 deletion syndrome: a novel clinically recognisable genetic condition identified by array comparative genomic hybridisation.
    Malan V; Raoul O; Firth HV; Royer G; Turleau C; Bernheim A; Willatt L; Munnich A; Vekemans M; Lyonnet S; Cormier-Daire V; Colleaux L
    J Med Genet; 2009 Sep; 46(9):635-40. PubMed ID: 19126570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion 2q37.3 and autism: molecular cytogenetic mapping of the candidate region for autistic disorder.
    Lukusa T; Vermeesch JR; Holvoet M; Fryns JP; Devriendt K
    Genet Couns; 2004; 15(3):293-301. PubMed ID: 15517821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features?
    Jaillard S; Dubourg C; Gérard-Blanluet M; Delahaye A; Pasquier L; Dupont C; Henry C; Tabet AC; Lucas J; Aboura A; David V; Benzacken B; Odent S; Pipiras E
    J Med Genet; 2009 Dec; 46(12):847-55. PubMed ID: 18812405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly recognised microdeletion syndrome involving 2p15p16.1: narrowing down the critical region by adding another patient detected by genome wide tiling path array comparative genomic hybridisation analysis.
    de Leeuw N; Pfundt R; Koolen DA; Neefs I; Scheltinga I; Mieloo H; Sistermans EA; Nillesen W; Smeets DF; de Vries BB; Knoers NV
    J Med Genet; 2008 Feb; 45(2):122-4. PubMed ID: 18245392
    [No Abstract]   [Full Text] [Related]  

  • 15. 2q31.1 microdeletion syndrome: redefining the associated clinical phenotype.
    Dimitrov B; Balikova I; de Ravel T; Van Esch H; De Smedt M; Baten E; Vermeesch JR; Bradinova I; Simeonov E; Devriendt K; Fryns JP; Debeer P
    J Med Genet; 2011 Feb; 48(2):98-104. PubMed ID: 21068127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interstitial deletion of 18q: comparative genomic hybridization array analysis of 46, XX,del(18)(q21.2.q21.33).
    Kato Z; Morimoto W; Kimura T; Matsushima A; Kondo N
    Birth Defects Res A Clin Mol Teratol; 2010 Feb; 88(2):132-5. PubMed ID: 19813260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interstitial deletion of chromosome 2p15-16.1: report of two patients and critical review of current genotype-phenotype correlation.
    Piccione M; Piro E; Serraino F; Cavani S; Ciccone R; Malacarne M; Pierluigi M; Vitaloni M; Zuffardi O; Corsello G
    Eur J Med Genet; 2012 Apr; 55(4):238-44. PubMed ID: 22406401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between deletion size and important phenotypes expands the genomic region of interest in Phelan-McDermid syndrome (22q13 deletion syndrome).
    Sarasua SM; Dwivedi A; Boccuto L; Rollins JD; Chen CF; Rogers RC; Phelan K; DuPont BR; Collins JS
    J Med Genet; 2011 Nov; 48(11):761-6. PubMed ID: 21984749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new genomic duplication syndrome complementary to the velocardiofacial (22q11 deletion) syndrome.
    Hassed SJ; Hopcus-Niccum D; Zhang L; Li S; Mulvihill JJ
    Clin Genet; 2004 May; 65(5):400-4. PubMed ID: 15099348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome.
    Redon R; Baujat G; Sanlaville D; Le Merrer M; Vekemans M; Munnich A; Carter NP; Cormier-Daire V; Colleaux L
    Eur J Hum Genet; 2006 Jun; 14(6):759-67. PubMed ID: 16570072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.